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Transformations in the glycolytic metabolism of neoplasms modulate their robust cellular division. This characteristic leads to an “addiction” to glucose
for continued proliferation and viability. This study investigated whether glucose metabolites could rescue cellular viability in glucose-starvation conditions, a model of the inter-tumoral nutrient-deficient environment. Findings
illustrated potential cellular viability rescue with pyruvate addition in glucosedeprived conditions, yet the same potential was not observed with lactic acid,
a metabolite that exists at characteristically high concentrations within the
intertumoral microenvironment. These results could implicate a predominance
of certain metabolic pathways in nutrient-starved cells. Molecular transport
capacities across plasma membranes are tied closely to the effects of metabolites within the cell; therefore, the role of the MCT/CD147 transporter complex
in lactic acid oxidation was investigated and was found to noticeably enhance
this metabolic pathway.

Introduction
Cancer cells typically present with alterations in their cellular metabolism, most notably, a
bias toward aerobic glycolysis (Warburg Effect) and subsequent lactic acid production1,2.
This metabolic remodeling is far less efficient at generating ATP compared to oxidative
glucose metabolism; therefore, cancer cells must instigate an abnormally high level of
glucose and glutamine absorption to compensate. The increased uptake of glucose is accomplished by a cohort of factors, including HIF-1, Atk/mTOR, and c-Myc, which directly
modulate metabolic gene expression and enzymatic activities3. These metabolic manipulations are positive adaptive effects for a variety of reasons, including the reduction of
reactive oxygen species within the mitochondria and an increase in glycolic precursors for
biosynthetic processes4. Both of these effects are critical for the continued robust cellular
replication characteristic of aggressive cancers. This addiction to glycolysis has portrayed
tumor metabolism as an attractive target for novel cancer therapeutics5.
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Pyruvate kinase isotype M2 (M2-PK) was discovered to be one of the key enzymes
responsible for this enhanced aerobic glycolysis. Pyruvate kinase catalyses the final step
of glycolysis, transferring a phosphate group from its substrate, phosphoenolpyruvic acid
(PEP), to ADP, producing pyruvate and ATP. M2-PK, the dimeric form of pyruvate kinase,
has reduced affinity for PEP which results in a predominance of biosynthetic precursor
synthesis from glycolic intermediates instead of further oxidative metabolism. This shift is
essential for accelerated proliferation as many amino acids, nucleotides, and phospholipids
can be synthesized via these intermediates. This isotype is the predominant form associated with many cancers6, further implicating aerobic glycolysis as a positive adaptation in
tumorigenesis.
Similar metabolic reprogramming is observed in normal rapidly dividing cells in
which growth factors initiate accelerated cellular division and differentiation7. In the case
of cancer cells, however, metabolic transformation must be initiated in the metabolically
stressful and dynamic microenvironment of a solid tumor, in which essential nutrient concentrations are in constant flux8,9. The hyperbolic presence of glucose through layers of
the solid tumor leads to necrosis in the glucose-starved interior. In this study, the effects of
glucose deprivation were examined in two cancerous cell lines – B16-OVA, a mouse melanoma line, and Jurkat, a human leukemia line – and attempt to tease out potential rescuing capabilities of glucose metabolites. Simulating conditions similar to the inter-tumoral
nutrient-starved microenvironment can provide an understanding of how cancers maintain
their robust proliferation in metabolically hostile environments.

Materials and Methods
Tissue Culture
The B16-OVA, MEF, HeLa, and Pheonix cell lines were cultured in DMEM medium plus
10% fetal calf serum (FCS) and 1% NEAA, pyruvate, and penicillin/streptomycin. The
Jurkat cells were cultured in RPMI medium with identical additions. Pheonix cells were
transfected in Opti-MEM media. The glucose starvation (G-) medium was DMEM medium without pyruvate and glucose plus 10% dialyzed FCS and 1% NEAA and penicillin/
streptomycin. Cultures were grown for at least 5 days in G- medium supplemented with
11 mM glucose. Glucose was dissolved in Milli-Q water to 1.1 M then filtered to ensure
sterility. Sodium pyruvate and sodium lactate stocks were prepared at 4 M concentrations.
Transfections and transductions were performed with Lipofectamine 2000 [Invitrogen,
New York] and Polybrene [Millipore, Massachusetts] respectively. Nocodazole dosing for
cell cycle arrest was carried out under the following concentrations: 20 ng/mL for Jurkat,
25 ng/mL for HeLa, 50 ng/mL for MEF (SV40), and 75 ng/mL for B16-OVA.
Vectors
Vectors were provided by Dr. Ruoning Wang (St. Jude Children’s Research Hospital,
Memphis, Tennessee). They were constructed in the pCMV background with the following inserts: (1) pIRES-MCT1-2A-CD147, (2) pIRES-MCT4-2A-CD147, (3) pGFP-v-RSmPDK1-shRNA, (4) pGFP-v-RS-LDHa-shRNA, (5) shRNAø. 2A linkages were designed
according to previous literature10,11.

Western Blot Analysis
Freshly isolated cells were spun down and the pellet was dissolved in 5 volumes of RIPA
buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X
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100) with 1:200 phenylmethanesulfonylfluoride (PMSF). After incubation on ice for 15
minutes, insoluble components were removed through centrifugation (10,000g, 10 minutes). Proteins in the supernatant were separated on Criterion XT [Bio-Rad, California]
gels and transferred to Hybond-C Extra [Amersham Biosciences, Pennsylvania] membranes. Antibodies described below.
Flow Cytometry
All flow cytometry was performed using FACS Calibur [Becton Dickinson, New Jersey]
equipment in combination with Cell Quest Pro [BD Biosciences, New Jersey]. Data was
analyzed using FlowJo [Tree Star, Oregon].

Antibodies
Immune antibodies used as cell death markers include Annexin V [eBioscience, California]
at 1:200 concentration and 7-AAD [eBioscience, California] at 1:20 concentration. Cell
cycle analysis was completed with hypotonic PI buffer – 0.1% Triton-X100, 0.1% sodium
citrate, 50 mg/mL PI – as well as aHistone H3 [BD Biosciences] at 1:100 concentration.
CD98 and CD147 expression was determined using aHu CD147 and CD98 [eBioscience]
and aMo CD147 and CD98 [eBioscience]. Western blot analysis was performed using
aPDK and aLDH [Santa Cruz Biotechnology] at 1:1000 concentration and a2A described
in previous literature8,9 at 1:1000 concentrations.

Metabolic Assays
Glycolytic flux was determined by measuring the detritiation of [3-3H]-glucose. Lactic
Acid oxidation flux was determined by the rate of 14CO2 released from [U-14C]-lactic acid.
Both metabolic flux assays were determined by scintillation counters.

Results
Pyruvate partially rescues cellular viability whereas lactic acid shows no significant
effect: Rapid decline of cellular viability in B16-OVA and Jurkat lines under glucose starvation environments supported previous data on the nutrient dependence of glucose8,9 [Fig.
1]. Upon investigation of the rescuing capabilities of glucose metabolites, pyruvate demonstrated modest cellular rescue at 10 mM concentrations [Fig. 2], whereas lactate displayed
no sustainable positive effects at 10, 20, and 40 mM concentrations. Syncronization of
the cell cycle in B16 and Jurkat cultures further supported evidence that pyruvate effectively rescued cell viability [Fig. 3,4]. Furthermore, the rescuing capacity of pyruvate was
more impressive in syncronized cells. Syncronization was accomplished by treatment with
nocodazole (NOC), an anti-neoplasm agent that prevents cellular division by inhibiting
spindle fiber formation during mitosis. NOC induces a moderate degree of cell death in
culture, therefore all results were normalized for the effect of NOC treatment alone.
Overexpression of MCT/CD147 transporter complex induces increased lactic acid
oxidation: The ability of metabolites to benefit cellular survival depends greatly on their
ability to be transported across the plasma membrane, suggesting an important role for
MCT/CD147 transporter complex in lactic acid oxidation. To investigate the effects of
MCT/CD147 transporter complex expression on metabolic events, stable MEF (SV40)
and B16-OVA lines overexpressing murine MCT1 or human MCT4 were generated. The
intent was to elucidate potential variables that could lead to increased cellular viability
with lactic acid supplements in glucose starvation environments. Using radiolabeled lactic
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acid, an obserable increase in lactic acid oxidation was observed in both MCT1 and MCT4
B16-OVA transfectant lines as well as in the MCT1 MEF transfectant line [Fig. 5]. Rates of
oxidative glucose metabolism my also be increased, albeit much less dramatically. These
results were anticipated however, as Glut-1 is the primary glucose transporter in mamalian
cells and the MCT/CD147 transporter complex could also serve as a transport for glucose
and its metabolites.

Discussion
Robust cell death in glucose starvation environments was anticipated [Fig 1], as the media
was stripped of all glucose metabolites. Glutamine was still present in the media, yet it did
not provide any long-term rescuing effects. Short-term rescuing capacity of this nutrient
was not examined. Pyruvate showed the highest rescuing capabilities compared to lactic
acid [Fig 2], potentially illustrating that MCT/CD147 transporter complex plays a large role
in metabolite effects within the cell. This contradicted the initial hypothesis as it was anticipated that lactic acid would show rescuing effects due to its increased concentration in tumor mincroenvironments, a well documented phenomenon1,2,3,8,9. The role of MCT/CD147
transporter complex in metaolic events within the cell was analyzed by metabolic analysis
of lactic acid oxidation in cells with MCT/CD147 overexpression [Fig. 5]. Significant increases in metabolic rates in the transporter overexpression lines was observed, thereby
providing a possible cause for the lack of rescuing effects in previous experiments. Briefly,
insufficient lactic acid absorption rates could be attibuted to low endogenous MCT/CD147
transporter complex expression in WT B16-OVA and Jurkat cell lines, thereby inhibiting
the potential for metabolic rescue via lactic acid metabolism. Future studies will examine
these MCT/CD147 transfectants in glucose deprivation environments to identify potential
increases in glucose metabolite rescue.
Cellular replication is an energetically expensive event; therefore, efforts were made
to synchronize the majority of the culture population into one particular phase of the cell
cycle [Fig. 3]. Synchronizing cell cycles eliminates extraneous variables that could alter
cellular viability results, as cells undergoing one particular phase of the cell cycle may be
more susceptible to apoptosis in nutrient-deprived environments. Following M-phase arrest by nocodazole treatment, the cells were released into various starvation environments
[Fig. 4]. These results provide a more accurate representation of the necessity of glucose
in cellular replication as well as the rescuing capacity of pyruvate. Further studies will
examine rescuing effects of glucose metabolites in the MCT/CD147 overexpression lines
following cell cycle synchronization.
In attempts to direct cellular metabolism against certain pathways, MEF (SV40)
and B16-OVA cells were transduced with either lactate dehydrogenase A (LDHa) or pyruvate dehydrogenase kinase type 1 (PDK1) shRNA constructs. Knocking down PDK1 or
LDHa would create a bias towards oxidative metabolism by promoting acetyl-coenzyme
A conversion or inhibiting lactic acid production, respectively. However, no obserable
knockdown was achieved, suggesting either a misfunction of the shRNA construct, or potentially, the dependence on these metabolic enzymes in cellular viability and proliferation.
These enzymes play crucial roles in metabolic reprogramming, disfavoring the oxidative
metabolism of pyruvate, in a variety of cell types, including numerous cancer cell lines9.
Conditional-expression transfectants will be generated to examine knockdown of these
enzymes in future experiments.
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From this study, the rescuing effects of glucose metabolites have illustrated how cancerous cells may adapt to the intertumoral nutrient-deprived microenvironment. Nutrient
rescuing capacity may be related to the cell’s ability to transport nutrients across the cellular
membrane12. In examination of the effects of MCT/CD147 transporter complex overexpression, this tenant held true, as cellular viability was higher in overexpression lines. These experiments illustrate some of the mechanics of metabolic reprogramming within cancer cells,
most notably, the metabolism of glucose metabolites in glucose-deprived environments as
well as the importance of transporter expression in rescuing cellular viability.
In the future, the rescuing capacity of these glucose metabolites will be examined in
more physiologically relevant conditions. This can be accomplished by developing 3D cell
cultures in conditions mimicking the inter-tumoral environment, for example by reducing
oxygen concentrations. The microenvironment surrounding the tumor plays a major role in
its metabolic reprogramming events, therefore, to gauge a more accurate cellular response
to nutrient starvation, these differences between in vivo and in vitro cultures must be accounted for. Glutamine dependence in cancer cells will also be investigated. Glutamine
plays a pivitol role in replenishing citrate concentrations needed for lipidneogenesis, and
starvation of glutamine has been shown to drastically affect cellular viability13.
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Figure 1: Glucose Starvation of Jurkat and B16 cells.
Cells were cultured in DMEM media lacking pyruvate with 10% dialysized FBS for a
week. 5x105 cells were then seeded into a 6-well plate and incubated for 5 hours to allow
for adhesion of the B16 line. Cells were then washed twice with phosphate buffered saline
and covered in G- DMEM media. Cells were incubated for 12, 24, 30, 40 and 50 hours and
then stained with Annex V and 7AAD and analyzed via flow cytometry.

Figure 2: Metabolite Rescue of Jurkat (A) and B16-OVA (B).
Cells were cultured in DMEM media lacking pyruvate with 10% dialysized FBS for a
week. 5x105 cells were then seeded into a 6-well plate and incubated for 5 hours to allow
for adhesion of the B16 line. Cells were then washed twice with phosphate buffered saline
and covered in G- DMEM media with the appropriate metabolite supplement. The control
line was supplemented with 11 mM glucose. Cells were incubated for he indicated hours
and then stained with Annexin V and 7AAD. Cell death was analyzed via flow cytometry.
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Figure 3: PI and Histone-H3 staining of Jurkat cell line with nocodazole treatment.
Jurkat cells were cultured in standard DMEM media. 5x105 Jurkat cells were seeded onto
a 6 well plate with (C&D) and without (A&B) the addition of 20 ng/mL nocodazole.
Following a 24 hour incubation, the cells were collected and fixed in a hypotonic PI solution with 1:100 αHistone-H3 (APC). Cell death was analyzed via flow cytometry.
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Figure 4: Pyruvate rescue of Jurkat cellular viability following cell cycle
synchronization.
Jurkat cells were cultured in DMEM media lacking pyruvate with 10% dialysized FBS for
a week. 5x105 cells were then seeded into a 6-well plate. Cell cultures were subjected to 20
ng/mL nocodazole treatment and incubated for 24 hours for cell cycle arrest. Cultures were
then washed twice with PBS and placed in fresh G- media with respective nutrient supplements. Cell death was analyzed via flow cytometry.
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